A citation-based method for searching scientific literature

Alex Mas Monteys, Shauna A Ebanks, Megan S Keiser, Beverly L Davidson. Mol Ther 2017
Times Cited: 136



Hao Yin, Chun-Qing Song, Joseph R Dorkin, Lihua J Zhu, Yingxiang Li, Qiongqiong Wu, Angela Park, Junghoon Yang, Sneha Suresh, Aizhan Bizhanova, Ankit Gupta, Mehmet F Bolukbasi, Stephen Walsh, Roman L Bogorad, Guangping Gao, Zhiping Weng, Yizhou Dong, Victor Koteliansky, Scot A Wolfe, Robert Langer, Wen Xue, Daniel G Anderson. Nat Biotechnol 2016
Times Cited: 483




List of shared articles



Times cited

Revisiting gene delivery to the brain: silencing and editing.
João Conniot, Sepehr Talebian, Susana Simões, Lino Ferreira, João Conde. Biomater Sci 2021
4

Approach for in vivo delivery of CRISPR/Cas system: a recent update and future prospect.
Yu-Fan Chuang, Andrew J Phipps, Fan-Li Lin, Valerie Hecht, Alex W Hewitt, Peng-Yuan Wang, Guei-Sheung Liu. Cell Mol Life Sci 2021
4

CRISPR/Cas-Dependent and Nuclease-Free In Vivo Therapeutic Gene Editing.
Ishani Dasgupta, Terence R Flotte, Allison M Keeler. Hum Gene Ther 2021
6

Chromatin Alterations in Neurological Disorders and Strategies of (Epi)Genome Rescue.
Marcin Janowski, Małgorzata Milewska, Peyman Zare, Aleksandra Pękowska. Pharmaceuticals (Basel) 2021
0

Genome editing methods in animal models.
Hyunji Lee, Da Eun Yoon, Kyoungmi Kim. Anim Cells Syst (Seoul) 2020
11

CRISPR-Cas9 system: A genome-editing tool with endless possibilities.
Swati Tyagi, Robin Kumar, Aparup Das, So Youn Won, Pratyoosh Shukla. J Biotechnol 2020
9

The delivery challenge: fulfilling the promise of therapeutic genome editing.
Joost van Haasteren, Jie Li, Olivia J Scheideler, Niren Murthy, David V Schaffer. Nat Biotechnol 2020
39

Delivery Approaches for Therapeutic Genome Editing and Challenges.
Ilayda Ates, Tanner Rathbone, Callie Stuart, P Hudson Bridges, Renee N Cottle. Genes (Basel) 2020
13

Delivery of CRISPR/Cas9 by Novel Strategies for Gene Therapy.
Le Wang, Wenfu Zheng, Shaoqin Liu, Bing Li, Xingyu Jiang. Chembiochem 2019
20

Rare Opportunities: CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases.
Panayiota Papasavva, Marina Kleanthous, Carsten W Lederer. Mol Diagn Ther 2019
12

CRISPR editing in biological and biomedical investigation.
Jiaojiao Huang, Yanfang Wang, Jianguo Zhao. J Cell Physiol 2018
10

Immunity to CRISPR Cas9 and Cas12a therapeutics.
Wei Leong Chew. Wiley Interdiscip Rev Syst Biol Med 2018
59

In vivo genome editing thrives with diversified CRISPR technologies.
Xun Ma, Avery Sum-Yu Wong, Hei-Yin Tam, Samuel Yung-Kin Tsui, Dittman Lai-Shun Chung, Bo Feng. Zool Res 2018
8